RSS   Newsletter   Contact   Advertise with us

GSK and Sanofi in talks to supply 300m vaccine doses to EU

Christian Fernsby ▼ | August 3, 2020
GlaxoSmithKline and Sanofi said they were in advanced talks with the European Commission to supply up to 300m doses of a coronavirus vaccine.
Companies   GSK

Topics: GSK Sanofi The companies said the vaccine candidate was developed by Sanofi in partnership with GSK and is based on Sanofi technology used to produce an influenza vaccine and GSK's adjuvant technology.